237 related articles for article (PubMed ID: 33090973)
1. Graft-versus-host disease depletes plasmacytoid dendritic cell progenitors to impair tolerance induction.
Tian Y; Meng L; Wang Y; Li B; Yu H; Zhou Y; Bui T; Abraham C; Li A; Zhang Y; Wang J; Zhao C; Mineishi S; Gallucci S; Porter D; Hexner E; Zheng H; Zhang Y; Hu S; Zhang Y
J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33090973
[TBL] [Abstract][Full Text] [Related]
2. Enrichment of IL-12-producing plasmacytoid dendritic cells in donor bone marrow grafts enhances graft-versus-leukemia activity in allogeneic hematopoietic stem cell transplantation.
Darlak KA; Wang Y; Li JM; Harris WA; Owens LM; Waller EK
Biol Blood Marrow Transplant; 2013 Sep; 19(9):1331-9. PubMed ID: 23810844
[TBL] [Abstract][Full Text] [Related]
3. Graft-versus-host disease prevents the maturation of plasmacytoid dendritic cells.
Banovic T; Markey KA; Kuns RD; Olver SD; Raffelt NC; Don AL; Degli-Esposti MA; Engwerda CR; MacDonald KP; Hill GR
J Immunol; 2009 Jan; 182(2):912-20. PubMed ID: 19124734
[TBL] [Abstract][Full Text] [Related]
4. Plasmacytoid dendritic cells prime alloreactive T cells to mediate graft-versus-host disease as antigen-presenting cells.
Koyama M; Hashimoto D; Aoyama K; Matsuoka K; Karube K; Niiro H; Harada M; Tanimoto M; Akashi K; Teshima T
Blood; 2009 Feb; 113(9):2088-95. PubMed ID: 19144988
[TBL] [Abstract][Full Text] [Related]
5. Mobilized Multipotent Hematopoietic Progenitors Promote Expansion and Survival of Allogeneic Tregs and Protect Against Graft Versus Host Disease.
D'Aveni M; Notarantonio AB; Agbogan VA; Bertrand A; Fouquet G; Gastineau P; Garfa-Traoré M; De Carvalho M; Hermine O; Rubio MT; Zavala F
Front Immunol; 2020; 11():607180. PubMed ID: 33643294
[TBL] [Abstract][Full Text] [Related]
6. IFN-γ and indoleamine 2,3-dioxygenase signaling between donor dendritic cells and T cells regulates graft versus host and graft versus leukemia activity.
Lu Y; Giver CR; Sharma A; Li JM; Darlak KA; Owens LM; Roback JD; Galipeau J; Waller EK
Blood; 2012 Jan; 119(4):1075-85. PubMed ID: 22130799
[TBL] [Abstract][Full Text] [Related]
7. Donor plasmacytoid dendritic cells limit graft-versus-host disease through vasoactive intestinal polypeptide expression.
Zhu J; Wang Y; Li J; Das PK; Zhang H; Passang T; Li JM; Nagy T; Gandhi K; Ravindranathan S; Giver CR; Hassan M; Li Y; Antonova AU; Wang S; Roback JD; Waller EK
Blood; 2022 Sep; 140(12):1431-1447. PubMed ID: 35443019
[TBL] [Abstract][Full Text] [Related]
8. Flt3L Treatment of Bone Marrow Donors Increases Graft Plasmacytoid Dendritic Cell Content and Improves Allogeneic Transplantation Outcomes.
Hassan M; Ulezko Antonova A; Li JM; Hosoba S; Rupji M; Kowalski J; Perricone AJ; Jaye DL; Marsh H; Yellin M; Devine S; Waller EK
Biol Blood Marrow Transplant; 2019 Jun; 25(6):1075-1084. PubMed ID: 30503387
[TBL] [Abstract][Full Text] [Related]
9. Reconstitution dynamics of plasmacytoid and myeloid dendritic cell precursors after allogeneic myeloablative hematopoietic stem cell transplantation.
Fagnoni FF; Oliviero B; Giorgiani G; De Stefano P; Dehò A; Zibera C; Gibelli N; Maccario R; Da Prada G; Zecca M; Locatelli F
Blood; 2004 Jul; 104(1):281-9. PubMed ID: 15010368
[TBL] [Abstract][Full Text] [Related]
10. Assessing the development of murine plasmacytoid dendritic cells in Peyer's patches using adoptive transfer of hematopoietic progenitors.
Li HS; Watowich SS
J Vis Exp; 2014 Mar; (85):. PubMed ID: 24686788
[TBL] [Abstract][Full Text] [Related]
11. CD4+ T cells generated de novo from donor hemopoietic stem cells mediate the evolution from acute to chronic graft-versus-host disease.
Zhang Y; Hexner E; Frank D; Emerson SG
J Immunol; 2007 Sep; 179(5):3305-14. PubMed ID: 17709547
[TBL] [Abstract][Full Text] [Related]
12. Increased engraftment and GVHD after in utero transplantation of MHC-mismatched bone marrow cells and CD80low, CD86(-) dendritic cells in a fetal mouse model.
Chou SH; Chawla A; Lee TH; Zhou Y; Busch MP; Balassanian R; Ferrell L; Cowan MJ
Transplantation; 2001 Dec; 72(11):1768-76. PubMed ID: 11740386
[TBL] [Abstract][Full Text] [Related]
13. Recipient-Derived Allo-iTregs Induced by Donor DCs Effectively Inhibit the Proliferation of Donor T Cells and Reduce GVHD.
Yang ZG; Wen RT; Feng JS; Cao PJ; Zhou HT; Liu WX
Anat Rec (Hoboken); 2019 May; 302(5):825-836. PubMed ID: 30312018
[TBL] [Abstract][Full Text] [Related]
14. Programming of donor T cells using allogeneic δ-like ligand 4-positive dendritic cells to reduce GVHD in mice.
Mochizuki K; Meng L; Mochizuki I; Tong Q; He S; Liu Y; Purushe J; Fung H; Zaidi MR; Zhang Y; Reshef R; Blazar BR; Yagita H; Mineishi S; Zhang Y
Blood; 2016 Jun; 127(25):3270-80. PubMed ID: 27143255
[TBL] [Abstract][Full Text] [Related]
15. Low Counts of Plasmacytoid Dendritic Cells after Engraftment Are Associated with High Early Mortality after Allogeneic Stem Cell Transplantation.
Gonçalves MV; Yamamoto M; Kimura EY; Colturato VA; de Souza MP; Mauad M; Ikoma MV; Novis Y; Rocha V; Ginani VC; Wanderley de Oliveira Felix OM; Seber A; Kerbauy FR; Hamerschlak N; Orfao A; Rodrigues CA
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1223-9. PubMed ID: 25792371
[TBL] [Abstract][Full Text] [Related]
16. Absence of STAT1 in donor-derived plasmacytoid dendritic cells results in increased STAT3 and attenuates murine GVHD.
Capitini CM; Nasholm NM; Chien CD; Larabee SM; Qin H; Song YK; Klover PJ; Hennighausen L; Khan J; Fry TJ
Blood; 2014 Sep; 124(12):1976-86. PubMed ID: 25079358
[TBL] [Abstract][Full Text] [Related]
17. Improved survival after transplantation of more donor plasmacytoid dendritic or naïve T cells from unrelated-donor marrow grafts: results from BMTCTN 0201.
Waller EK; Logan BR; Harris WA; Devine SM; Porter DL; Mineishi S; McCarty JM; Gonzalez CE; Spitzer TR; Krijanovski OI; Linenberger ML; Woolfrey A; Howard A; Wu J; Confer DL; Anasetti C
J Clin Oncol; 2014 Aug; 32(22):2365-72. PubMed ID: 24982459
[TBL] [Abstract][Full Text] [Related]
18. Rapid reconstitution of functionally active 6-sulfoLacNAc(+) dendritic cells (slanDCs) of donor origin following allogeneic haematopoietic stem cell transplant.
Mimiola E; Marini O; Perbellini O; Micheletti A; Vermi W; Lonardi S; Costantini C; Meneghelli E; Andreini A; Bonetto C; Vassanelli A; Cantini M; Zoratti E; Massi D; Zamo' A; Leso A; Quaresmini G; Benedetti F; Pizzolo G; Cassatella MA; Tecchio C
Clin Exp Immunol; 2014 Oct; 178(1):129-41. PubMed ID: 24853271
[TBL] [Abstract][Full Text] [Related]
19. The signal transducer STAT5 inhibits plasmacytoid dendritic cell development by suppressing transcription factor IRF8.
Esashi E; Wang YH; Perng O; Qin XF; Liu YJ; Watowich SS
Immunity; 2008 Apr; 28(4):509-20. PubMed ID: 18342552
[TBL] [Abstract][Full Text] [Related]
20. Impaired interferon-alpha production by plasmacytoid dendritic cells after cord blood transplantation in children: implication for post-transplantation toll-like receptor ligand-based immunotherapy.
Charrier E; Cordeiro P; Brito RM; Harnois M; Mezziani S; Herblot S; Le Deist F; Duval M
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1501-7. PubMed ID: 25128615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
